Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 139,400 shares, an increase of 26.3% from the March 15th total of 110,400 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average daily volume of 143,900 shares, the days-to-cover ratio is presently 1.0 days.
Crescent Capital BDC Stock Performance
NASDAQ:CCAP traded down $0.43 during mid-day trading on Monday, hitting $15.07. 84,574 shares of the stock were exchanged, compared to its average volume of 143,312. The firm’s 50-day simple moving average is $17.22 and its 200 day simple moving average is $18.41. The stock has a market capitalization of $558.52 million, a price-to-earnings ratio of 7.57 and a beta of 0.56. Crescent Capital BDC has a fifty-two week low of $13.54 and a fifty-two week high of $20.19. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last announced its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The business had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. As a group, equities analysts anticipate that Crescent Capital BDC will post 2.09 EPS for the current fiscal year.
Crescent Capital BDC Announces Dividend
Analyst Ratings Changes
A number of equities analysts recently commented on CCAP shares. Wells Fargo & Company lowered their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Friday, February 21st. Keefe, Bruyette & Woods decreased their target price on Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating on the stock in a report on Tuesday, April 8th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.90.
Read Our Latest Stock Analysis on Crescent Capital BDC
Institutional Investors Weigh In On Crescent Capital BDC
Several institutional investors have recently made changes to their positions in CCAP. First Affirmative Financial Network acquired a new position in Crescent Capital BDC in the 1st quarter valued at $199,000. Confluence Investment Management LLC raised its stake in Crescent Capital BDC by 1.6% in the first quarter. Confluence Investment Management LLC now owns 75,052 shares of the company’s stock valued at $1,285,000 after purchasing an additional 1,213 shares in the last quarter. Pettinga Financial Advisors LLC raised its stake in Crescent Capital BDC by 57.7% in the fourth quarter. Pettinga Financial Advisors LLC now owns 45,767 shares of the company’s stock valued at $880,000 after purchasing an additional 16,750 shares in the last quarter. Millennium Management LLC lifted its position in Crescent Capital BDC by 23.2% during the fourth quarter. Millennium Management LLC now owns 87,134 shares of the company’s stock worth $1,675,000 after purchasing an additional 16,402 shares during the period. Finally, Cetera Investment Advisers grew its stake in Crescent Capital BDC by 12.9% during the fourth quarter. Cetera Investment Advisers now owns 18,712 shares of the company’s stock worth $360,000 after buying an additional 2,141 shares in the last quarter. 49.46% of the stock is currently owned by institutional investors.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- Bank Stocks – Best Bank Stocks to Invest In
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.